terry white chemists perindopril perindopril erbumine 4mg tablets blister pack
apotex pty ltd - perindopril erbumine -
terry white chemists perindopril perindopril erbumine 2mg tablets blister pack
apotex pty ltd - perindopril erbumine -
chemmart perindopril perindopril erbumine 4mg tablets blister pack
apotex pty ltd - perindopril erbumine -
chemmart perindopril perindopril erbumine 2mg tablets blister pack
apotex pty ltd - perindopril erbumine -
pharmacy clinice perindopril perindopril erbumine 8mg tablets blister pack
gm pharma international pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.
ozapace perindopril erbumine 8 mg tablet blister pack
sun pharma anz pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate - ozapace is indicated for: the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that ozapace be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
arrow-perindopril 8 perindopril erbumine 8mg tablets blister pack
arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients, it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials), who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
perindopril and indapamide-bw 4/1.25 mg tablets perindopril erbumine 4mg and indapamide hemihydrate1.25mg tablet blister pack
lupin australia pty limited - indapamide hemihydrate,perindopril erbumine -
indopril 4 perindopril erbumine 4mg tablet blister pack
arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; silica dimethyl silylate; lactose monohydrate - indopril 4 is indicated for: the treatment of hypertension.the treatment of heart failure. in such patients it is recommended that indopril 4 be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril tablets have not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
indopril 2 perindopril erbumine 2mg tablet blister pack
arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; silica dimethyl silylate - indopril 2 is indicated for: the treatment of hypertension.the treatment of heart failure. in such patients it is recommended that indopril 2 be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril tablets have not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.